Stock BJDX BLUEJAY DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Bluejay Diagnostics, Inc.

Equities

BJDX

US0956334009

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-05 pm EDT 		5-day change 1st Jan Change
0.5964 USD -5.33% Intraday chart for Bluejay Diagnostics, Inc. -14.70% -93.89%
Jun. 28 Bluejay Diagnostics Closes $8.8 Million Public Offering MT
Jun. 27 Top Midday Decliners MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Bluejay Diagnostics Closes $8.8 Million Public Offering
MT
Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering
AQ
Top Midday Decliners
MT
Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data
MT
Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering
AQ
US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data
MT
SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients
AQ
Buejay Diagnostics, Inc Announces Results from the Primary Analysis of SYMON-I
CI
Bluejay Diagnostics Announces Reverse Stock Split
AQ
Bluejay Diagnostics, Inc. announced a financing transaction
CI
Bluejay Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Bluejay Diagnostics, Inc. Appoints Neil Dey as Principal Financial and Accounting Officer
CI
Bluejay Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
AQ
Top Premarket Decliners
MT
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering
AQ
Top Midday Decliners
MT
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients
CI
Bluejay Diagnostics Starts Clinical Study of Symphony IL-6 Test in Sepsis Patients; Shares Fall
MT
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BJDX Stock
  4. News Bluejay Diagnostics, Inc.